Oncode Accelerator has announced a leadership transition that will further strengthen the alignment between Oncode Institute and the Oncode Accelerator. As of 1 April, Bertholt Leeftink, Managing Director of Oncode Institute, will also take on the role of CEO and Chair of the Board of Directors of Oncode Accelerator.

This step reflects the close collaboration between both organisations, which work across complementary stages of the innovation chain, from fundamental discovery to the development of new cancer therapies.

Arnoud Huisman will resign from his role as CEO and Chair of the Board of Directors of Oncode Accelerator on 1 April, after playing an important role in establishing the foundation and building the programme together with its partners. You can read the full press release on the Oncode Accelerator website.